Cargando…

P1243: RUXOLITINIB COMBINED WITH DEXAMETHASONE IN ADULT PATIENTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INTERIM ANALYSIS OF A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM, PHASE 2 CLINICAL TRIAL

Detalles Bibliográficos
Autores principales: Zhou, D., Huang, X., Li, X., Zhu, L., Xie, M., Ma, L., Yang, X., Sun, J., Li, L., Zhu, J., Zheng, X., Zhao, S., Yu, W., Xie, W., Tong, H., Jin, J., Zhu, H., Ye, X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429438/
http://dx.doi.org/10.1097/01.HS9.0000847836.30971.66
_version_ 1784779442766217216
author Zhou, D.
Huang, X.
Li, X.
Zhu, L.
Xie, M.
Huang, X.
Ma, L.
Yang, X.
Sun, J.
Li, L.
Zhu, J.
Zheng, X.
Zhao, S.
Yu, W.
Xie, W.
Tong, H.
Jin, J.
Zhu, H.
Ye, X.
author_facet Zhou, D.
Huang, X.
Li, X.
Zhu, L.
Xie, M.
Huang, X.
Ma, L.
Yang, X.
Sun, J.
Li, L.
Zhu, J.
Zheng, X.
Zhao, S.
Yu, W.
Xie, W.
Tong, H.
Jin, J.
Zhu, H.
Ye, X.
author_sort Zhou, D.
collection PubMed
description
format Online
Article
Text
id pubmed-9429438
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94294382022-08-31 P1243: RUXOLITINIB COMBINED WITH DEXAMETHASONE IN ADULT PATIENTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INTERIM ANALYSIS OF A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM, PHASE 2 CLINICAL TRIAL Zhou, D. Huang, X. Li, X. Zhu, L. Xie, M. Huang, X. Ma, L. Yang, X. Sun, J. Li, L. Zhu, J. Zheng, X. Zhao, S. Yu, W. Xie, W. Tong, H. Jin, J. Zhu, H. Ye, X. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429438/ http://dx.doi.org/10.1097/01.HS9.0000847836.30971.66 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Zhou, D.
Huang, X.
Li, X.
Zhu, L.
Xie, M.
Huang, X.
Ma, L.
Yang, X.
Sun, J.
Li, L.
Zhu, J.
Zheng, X.
Zhao, S.
Yu, W.
Xie, W.
Tong, H.
Jin, J.
Zhu, H.
Ye, X.
P1243: RUXOLITINIB COMBINED WITH DEXAMETHASONE IN ADULT PATIENTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INTERIM ANALYSIS OF A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM, PHASE 2 CLINICAL TRIAL
title P1243: RUXOLITINIB COMBINED WITH DEXAMETHASONE IN ADULT PATIENTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INTERIM ANALYSIS OF A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM, PHASE 2 CLINICAL TRIAL
title_full P1243: RUXOLITINIB COMBINED WITH DEXAMETHASONE IN ADULT PATIENTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INTERIM ANALYSIS OF A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM, PHASE 2 CLINICAL TRIAL
title_fullStr P1243: RUXOLITINIB COMBINED WITH DEXAMETHASONE IN ADULT PATIENTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INTERIM ANALYSIS OF A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM, PHASE 2 CLINICAL TRIAL
title_full_unstemmed P1243: RUXOLITINIB COMBINED WITH DEXAMETHASONE IN ADULT PATIENTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INTERIM ANALYSIS OF A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM, PHASE 2 CLINICAL TRIAL
title_short P1243: RUXOLITINIB COMBINED WITH DEXAMETHASONE IN ADULT PATIENTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INTERIM ANALYSIS OF A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM, PHASE 2 CLINICAL TRIAL
title_sort p1243: ruxolitinib combined with dexamethasone in adult patients with newly diagnosed hemophagocytic lymphohistiocytosis: interim analysis of a prospective, single-center, single-arm, phase 2 clinical trial
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429438/
http://dx.doi.org/10.1097/01.HS9.0000847836.30971.66
work_keys_str_mv AT zhoud p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial
AT huangx p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial
AT lix p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial
AT zhul p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial
AT xiem p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial
AT huangx p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial
AT mal p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial
AT yangx p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial
AT sunj p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial
AT lil p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial
AT zhuj p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial
AT zhengx p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial
AT zhaos p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial
AT yuw p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial
AT xiew p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial
AT tongh p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial
AT jinj p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial
AT zhuh p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial
AT yex p1243ruxolitinibcombinedwithdexamethasoneinadultpatientswithnewlydiagnosedhemophagocyticlymphohistiocytosisinterimanalysisofaprospectivesinglecentersinglearmphase2clinicaltrial